Comparison between Basilic Fly Studio IPO and Saroja Pharma IPO.
Basilic Fly Studio IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.
| Basilic Fly Studio IPO | Saroja Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Swastika Investmart Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Share India Securities Ltd. | Swastika Investmart Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Basilic Fly Studio IPO is up to ₹56.40 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Basilic Fly Studio IPO is ₹97.00 per share and of Saroja Pharma IPO is ₹84.00 per share.
| Basilic Fly Studio IPO | Saroja Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹92.00 per share | |
| Issue Price (Upper) | ₹97.00 per share | |
| Issue Price (Final) | ₹97.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 52,14,000 shares | 10,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹50.58 Cr | up to ₹8.66 Cr |
| OFS Issue Size | 6,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹5.82 Cr | up to ₹0.00 Cr |
| Issue Size Total | 58,14,000 shares | 10,30,400 shares |
| Issue Size Total (Amount) | up to ₹56.40 Cr | up to ₹8.66 Cr |
Basilic Fly Studio IPO opens on Sep 01, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Basilic Fly Studio IPO and Saroja Pharma IPO is Sep 05, 2023, and Sep 05, 2023, respectively.
| Basilic Fly Studio IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Aug 31, 2023 | |
| Issue Open | Sep 01, 2023 | Aug 31, 2023 |
| Issue Close | Sep 05, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 11, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 12, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 13, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 11, 2023 | Sep 13, 2023 |
| Anchor Lockin End date 1 | Oct 11, 2023 | |
| Anchor Lockin End date 2 | Dec 10, 2023 |
Basilic Fly Studio IPO P/E ratio is 5.94, as compared to Saroja Pharma IPO P/E ratio of 23.27.
| Basilic Fly Studio IPO | Saroja Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
Amount in ₹ Lakhs |
Amount in ₹ Lakhs | |||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 85.42 | 100.00 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 5.94 | 23.27 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹225.43 Cr. | ₹33.77 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 155.63% | 0.15% | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 104.73% | 0.25% | |||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.14 | 2.00 | |||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹16.32 | ₹3.61 | |||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 87.59% | 20.85% |
In the Basilic Fly Studio IPO Retail Individual Investors (RII) are offered 20,35,200 shares while in Saroja Pharma IPO retail investors are offered 20,35,200 shares. Qualified Institutional Buyers (QIB) are offered 11,62,800 shares in Basilic Fly Studio IPO and in Saroja Pharma IPO.
| Basilic Fly Studio IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Investor Reserveration | 17,43,600 shares | |
| Market Maker Reserveration | 10,26,000 shares | 54,400 shares |
| QIB | 11,62,800 shares | |
| NII | 8,72,400 shares | 5,15,200 shares |
| RII | 20,35,200 shares | 5,15,200 shares |
| Employee | ||
| Others | ||
| Total | 58,14,000 shares | 10,30,400 shares |
Basilic Fly Studio IPO subscribed 358.60x in total, whereas Saroja Pharma IPO subscribed 8.88x.
| Basilic Fly Studio IPO | Saroja Pharma IPO | |
|---|---|---|
| QIB (times) | 116.34x | |
| NII (times) | 549.44x | 2.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 415.22x | 14.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 358.60x | 8.88x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
